Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapies are more effective for treating androgenetic alopecia than single treatments.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

Hair testing is a reliable method for detecting workplace drug use when done with proper sample preparation and confirmation.

Low-level laser therapy is the most supported treatment for hair loss, but other methods show promise.

PRP speeds up healing with few side effects, but more research is needed to standardize its use.

Testosterone is important for women's health, but more research is needed to guide its use.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

The ARTAS robotic system for hair restoration is efficient with fewer cuts than manual methods, but it's limited to certain hair types and can still leave scars.

The document warns against US clinics selling untested stem cell treatments without FDA approval.

Lasers are less favored for hair transplant surgery but show promise for hair growth in controlled trials.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Hair aging is inevitable, but using the right hair care products can help maintain hair health.

Lasers are FDA-approved for permanent hair reduction, not removal, and more research is needed to improve treatments.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

FDA-approved low-level light/laser therapy devices can significantly increase hair density in people with pattern hair loss.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Low-dose isotretinoin combined with pulsed azithromycin cleared acne in most patients, with mild side effects.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Low-speed protocols with certified centrifuges and FDA-approved glass tubes are best for effective PRF outcomes.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Online articles about alopecia areata are too hard to understand and need to be clearer.

Povidone iodine reduced skin bacteria more than chlorhexidine gluconate, but neither met FDA reduction standards.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

New psoriasis treatments are effective but come with side effects and risks.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Spironolactone is effective and safe for treating acne.